Identification of a c-MYB-directed therapeutic for acute myeloid leukemia. (2022)
Attributed to:
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-022-01554-9
PubMed Identifier: 35368048
Publication URI: http://europepmc.org/abstract/MED/35368048
Type: Journal Article/Review
Volume: 36
Parent Publication: Leukemia
Issue: 6
ISSN: 0887-6924